Association between Elimination Half-life of Benzodiazepines and Falls in the Elderly: A Meta-analysis of Observational Studies

  • Masudo Chikako
    Department of Pharmaceutical Science, Faculty of Pharmacy, Musashino University
  • Ogawa Yukari
    Department of Pharmaceutical Science, Faculty of Pharmacy, Musashino University
  • Yamashita Naomi
    Department of Pharmaceutical Science, Faculty of Pharmacy, Musashino University
  • Mihara Kiyoshi
    Department of Pharmaceutical Science, Faculty of Pharmacy, Musashino University

Bibliographic Information

Other Title
  • 高齢者におけるベンゾジアゼピン受容体作動薬の半減期と転倒との関連性:観察研究のメタアナリシス
  • コウレイシャ ニ オケル ベンゾジアゼ ピンウケ ヨウダイ サドウヤク ノ ハンゲンキ ト テントウ ト ノ カンレンセイ : カンサツ ケンキュウ ノ メタアナリシス

Search this article

Description

<p>Benzodiazepine receptor agonists (BZDRAs) have been associated with an increased risk of falls in the elderly. However, the association between the elimination half-life (t1/2) of BZDRAs and the difference between benzodiazepines (BZDs) and non-benzodiazepines (Z-drugs) has not been clarified. By conducting a meta-analysis of observational studies, we compared the risk of falls with respect to 1) short-acting BZDRAs (t1/2<12 h) vs. long-acting BZDRAs (t1/2≥12 h) and 2) BZDs vs. Z-drugs in elderly patients. Data were retrieved from MEDLINE, the Cochrane Library, and Igaku Chuo Zasshi. In total, 13 observational studies from 12 articles were included in our study (short-acting BZDRAs, n=12; long-acting BZDRAs, n=9; BZDs, n=13; Z-drugs, n=7). The risk of falls was significantly increased by the use of short-acting BZDRAs [Odds ratio (OR) (95% Confidence interval (CI)): 2.00 (1.46-2.73)], long-acting BZDRAs [OR (95%CI): 2.16 (1.61-2.89)], BZDs [OR (95%CI): 1.67 (1.31-2.13)], and Z-drugs [OR (95%CI): 2.42 (1.35-4.34)] compared to the risk in BZDRAs non-users. The increased risk of falls in elderly patients was similar in each group and unrelated to t1/2. This study suggested that all BZDRAs including Z-drugs should be avoided in elderly patients.</p>

Journal

  • YAKUGAKU ZASSHI

    YAKUGAKU ZASSHI 139 (1), 113-122, 2019-01-01

    The Pharmaceutical Society of Japan

Citations (1)*help

See more

References(29)*help

See more

Details 詳細情報について

Report a problem

Back to top